Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Comparison of energy consumption in different clinical forms multiple sclerosis with normal subjects (cohort study).
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Disease Activity during the First Year Predicts Clinical Long-Term Outcomes in Patients with Multiple Sclerosis: Fingolimod Treatment Benefit
Multiple sclerosis - a dynamic field with a need for excellent education.
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Multiple Sclerosis.
Fingolimod and cardiac risk: latest findings and clinical implications.
Vitamin d and multiple sclerosis: correlation, causality, and controversy.
Alphab-crystallin is a target for adaptive immune responses and a trigger of innate responses in preactive multiple sclerosis lesions.
Decreased serum IL-27 and IL-35 levels are associated with disease severity in neuromyelitis optica spectrum disorders.
[Symptoms and neurological findings in patients with multiple sclerosis].
Differential effects of myelin basic protein-activated Th1 and Th2 cells on the local immune microenvironment of injured spinal cord.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Microglia-Mediated Inflammation and Neurodegenerative Disease.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.
Clinical associations between gout and multiple sclerosis, Parkinson's disease and motor neuron disease: record-linkage studies.
A Single Amino Acid Substitution Prevents Recognition of a Dominant Human Aquaporin-4 Determinant in the Context of HLA-DRB1*03:01 by a Murine TCR.
A significant decrease in diagnosis of primary progressive multiple sclerosis: A cohort study.
Pain in acquired inflammatory demyelinating polyneuropathies.
[Sarcoid neuropathy].
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels.

Pages